Home › Products › Neurology › Gabawin ER 82.5mg Tablet
Gabawin ER 82.5mg Tablet
Salt Composition: PREGABALIN
- Manufacturer: ICON LIFE SCIENCES
- Pack Size: 10 TABLET(s) IN A STRIP
- Dosage Form: TABLET
- Strength: 82.5MG
- Prescription Required
- Storage: Keep out of sight and reach of pets and children. Do not freeze the medicine. Do not store above 30°C. Always check the expiry date before consuming it.
₹180.00₹225.00
Inclusive of all taxes
Product Introduction
Gabawin ER 82.5mg Tablet is an anti-epileptic or anticonvulsant drug containing the active ingredient Pregabalin. It belongs to the GABA analogue medication class, which works to prevent or reduce seizures in patients with epilepsy and certain other neurological disorders. This medicine is indicated for the treatment of epilepsy, generalised anxiety disorder (GAD), and neuropathic pain (pain arising from damaged nerves) in adults. It is also used to treat fibromyalgia (widespread body pain), nerve damage occurring in patients with diabetes, and spinal cord injury-related neuropathy. Gabawin ER 82.5mg Tablet should not be used if you are allergic to Pregabalin or any ingredients in the formulation. Before taking Gabawin ER 82.5mg Tablet, inform your doctor if you have experienced serious skin rashes including Stevens-Johnson syndrome and toxic epidermal necrolysis, dizziness, blurred or loss of vision, thoughts of self-harm, or suicidal behaviour. Also notify your doctor if you have gastrointestinal issues, convulsions, reduced brain function (encephalopathy), breathing difficulties, or a history of serious medical conditions including heart, liver, or kidney disease. Inform your doctor of any concerning symptoms or relevant medical history, as this medication is associated with these conditions and prompt notification is essential. This medicine is not recommended for use in children under 18 years of age. Dosage adjustment is required for patients with kidney impairment.
Uses
Gabawin ER 82.5mg Tablet is used in the treatment of the following: Generalised anxiety disorder (GAD) Diabetic peripheral neuropathy Epilepsy (type of seizure) Postherpetic neuropathy Fibromyalgia Neuropathic pain following spinal cord injury
How it works
Gabawin ER 82.5mg Tablet inhibits the high-voltage calcium channels in the central nervous system. It modulates the release of neurotransmitters such as norepinephrine and glutamate, reducing abnormal brain electrical activity and blockage of pain signal transmission.
How to Use
Take the Gabawin ER 82.5mg Tablet as your physician advises. Usually, the tablets will be taken with or without food. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious side effects of Gabawin ER 82.5mg Tablet include: Serious allergic reactions (swelling of the mouth, lips, gums, throat, tongue, troubled breathing, rash, raised bumps, and blisters) Sudden changes in mood, behaviours, thoughts, or feelings Swelling of hands, feet, and legs Weight gain Muscle problems, muscle pain, soreness, or weakness Problems with eyesight, including blurry vision Common side effects of Gabawin ER 82.5mg Tablet include: Sleepiness Trouble concentrating Dry mouth Dizziness Increase in appetite Drowsiness Headache
Expert Tips
Liver, heart, and kidney patients should take Gabawin ER 82.5mg Tablet cautiously. Inform their doctor about all the underlying medical conditions. Do not stop the medicine until your doctor advises. Do not double-dose the medicine to make up for a forgotten dose. Some patients with diabetes experience weight gain while taking Gabawin ER 82.5mg Tablet may need to adjust the dose of their diabetic medications. Do not breastfeed while taking Gabawin ER 82.5mg Tablet unless your doctor advises. Notify your doctor if you experience any serious side effects. Your medical professional will inform you if you need any dose adjustments. Contact your doctor for more information.
References
- MSN Laboratories Europe Limited, Electronic Medicines Compendium (EMC), [Revised on September 2022] [Accessed on 1st June 2023], *pil.13404.pdf (medicines.org.uk)
- Pfizer, US Food and Drug Administration; [Revised on May 2018] [Accessed on 1st June 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021446s035,022488s013lbl.pdf
- Sheena Derry et al; Pregabalin for neuropathic pain in adults; [Revised on 2019] [Accessed on 1st June 2023], https://pubmed.ncbi.nlm.nih.gov/30673120/
- Cross AL; Viswanath O; Sherman AI; Pregabalin; NCBI Bookshelf; [Revised on 2021] [Accessed on 1st June 2023], https://www.ncbi.nlm.nih.gov/books/NBK470341/#_NBK470341_pubdet_
Safety Advice
Pregnancy: Consult your doctor Taking Gabawin ER 82.5mg Tablet while pregnant may be unsafe because it may affect the unborn child. Notify your doctor if you are pregnant, planning to get pregnant, or think you may be pregnant.
Lungs: Consult your doctor It is unknown whether Gabawin ER 82.5mg Tablet is safe for patients with lung problems. Notify your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
Breastfeeding: unsafe Taking Gabawin ER 82.5mg Tablet while breastfeeding may be unsafe because it may affect the child. Inform your doctor if you are breastfeeding.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.